

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.12412941 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.12412941 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.82059085 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.82059085 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.53435300 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 5.99976623 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 5.99976623 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.99976623 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.88744518 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.73376043 |
| 11 | cysteine metabolic process (GO:0006534) | 5.73208680 |
| 12 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.67517119 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.67100647 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.51622368 |
| 15 | lysine catabolic process (GO:0006554) | 5.51547800 |
| 16 | lysine metabolic process (GO:0006553) | 5.51547800 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.46552398 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.45738179 |
| 19 | urea metabolic process (GO:0019627) | 5.28945952 |
| 20 | urea cycle (GO:0000050) | 5.28945952 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.28212351 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.26108517 |
| 23 | homocysteine metabolic process (GO:0050667) | 5.06428457 |
| 24 | intestinal cholesterol absorption (GO:0030299) | 5.05429015 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 5.03742577 |
| 26 | epoxygenase P450 pathway (GO:0019373) | 5.03671631 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.87047910 |
| 28 | complement activation, alternative pathway (GO:0006957) | 4.74012546 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 4.73574441 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.72635954 |
| 31 | bile acid metabolic process (GO:0008206) | 4.71183831 |
| 32 | * amino-acid betaine metabolic process (GO:0006577) | 4.66210096 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 4.65411169 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.64993964 |
| 35 | protein carboxylation (GO:0018214) | 4.64993964 |
| 36 | low-density lipoprotein particle remodeling (GO:0034374) | 4.61205310 |
| 37 | regulation of protein activation cascade (GO:2000257) | 4.61127408 |
| 38 | drug catabolic process (GO:0042737) | 4.60972484 |
| 39 | drug transmembrane transport (GO:0006855) | 4.58917137 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.55580536 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.52091435 |
| 42 | plasma lipoprotein particle organization (GO:0071827) | 4.50357121 |
| 43 | urate metabolic process (GO:0046415) | 4.49434498 |
| 44 | protein-lipid complex assembly (GO:0065005) | 4.48470004 |
| 45 | regulation of fibrinolysis (GO:0051917) | 4.44032371 |
| 46 | cellular ketone body metabolic process (GO:0046950) | 4.42426624 |
| 47 | blood coagulation, intrinsic pathway (GO:0007597) | 4.41187744 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.36462942 |
| 49 | regulation of complement activation (GO:0030449) | 4.33101108 |
| 50 | intestinal absorption (GO:0050892) | 4.32218351 |
| 51 | cellular amino acid catabolic process (GO:0009063) | 4.28080407 |
| 52 | serine family amino acid metabolic process (GO:0009069) | 4.25981636 |
| 53 | glutamate metabolic process (GO:0006536) | 4.25111358 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.24528967 |
| 55 | cellular modified amino acid catabolic process (GO:0042219) | 4.24151912 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.22837931 |
| 57 | triglyceride homeostasis (GO:0070328) | 4.22837931 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.21374183 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.21374183 |
| 60 | plasma lipoprotein particle remodeling (GO:0034369) | 4.18325402 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 4.18325402 |
| 62 | macromolecular complex remodeling (GO:0034367) | 4.18325402 |
| 63 | reverse cholesterol transport (GO:0043691) | 4.18310603 |
| 64 | regulation of cholesterol esterification (GO:0010872) | 4.18220798 |
| 65 | protein-lipid complex subunit organization (GO:0071825) | 4.16354505 |
| 66 | short-chain fatty acid metabolic process (GO:0046459) | 4.15757805 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.10968670 |
| 68 | amine catabolic process (GO:0009310) | 4.10743296 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 4.10743296 |
| 70 | cellular glucuronidation (GO:0052695) | 4.07752266 |
| 71 | glycine metabolic process (GO:0006544) | 4.06586673 |
| 72 | ethanol oxidation (GO:0006069) | 4.04634211 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 4.03378051 |
| 74 | phospholipid efflux (GO:0033700) | 4.02375861 |
| 75 | serine family amino acid biosynthetic process (GO:0009070) | 4.00323377 |
| 76 | coenzyme catabolic process (GO:0009109) | 3.99276754 |
| 77 | acetyl-CoA metabolic process (GO:0006084) | 3.98942492 |
| 78 | exogenous drug catabolic process (GO:0042738) | 3.96926148 |
| 79 | aspartate family amino acid catabolic process (GO:0009068) | 3.92080923 |
| 80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.90347169 |
| 81 | fatty acid beta-oxidation (GO:0006635) | 3.88588174 |
| 82 | plasma lipoprotein particle clearance (GO:0034381) | 3.87139716 |
| 83 | drug transport (GO:0015893) | 3.86645913 |
| 84 | carboxylic acid catabolic process (GO:0046395) | 3.84322010 |
| 85 | organic acid catabolic process (GO:0016054) | 3.84322010 |
| 86 | imidazole-containing compound metabolic process (GO:0052803) | 3.83910376 |
| 87 | fatty acid oxidation (GO:0019395) | 3.83406543 |
| 88 | 2-oxoglutarate metabolic process (GO:0006103) | 3.82658741 |
| 89 | regulation of cholesterol homeostasis (GO:2000188) | 3.81578746 |
| 90 | ketone body metabolic process (GO:1902224) | 3.81160087 |
| 91 | carnitine metabolic process (GO:0009437) | 3.79420607 |
| 92 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77033274 |
| 93 | lipid oxidation (GO:0034440) | 3.75775695 |
| 94 | valine metabolic process (GO:0006573) | 3.71312855 |
| 95 | negative regulation of protein activation cascade (GO:2000258) | 3.69675927 |
| 96 | monocarboxylic acid catabolic process (GO:0072329) | 3.68619649 |
| 97 | cholesterol efflux (GO:0033344) | 3.68375968 |
| 98 | uronic acid metabolic process (GO:0006063) | 3.68186489 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.68186489 |
| 100 | proline metabolic process (GO:0006560) | 3.67697404 |
| 101 | fatty acid catabolic process (GO:0009062) | 3.66433849 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.64241417 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.64184292 |
| 104 | plasma lipoprotein particle assembly (GO:0034377) | 3.60750436 |
| 105 | omega-hydroxylase P450 pathway (GO:0097267) | 3.60525368 |
| 106 | aldehyde catabolic process (GO:0046185) | 3.60292754 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.59853562 |
| 108 | arginine metabolic process (GO:0006525) | 3.59644158 |
| 109 | flavonoid metabolic process (GO:0009812) | 3.59256661 |
| 110 | sterol homeostasis (GO:0055092) | 3.57062990 |
| 111 | positive regulation of lipid catabolic process (GO:0050996) | 3.56472086 |
| 112 | drug metabolic process (GO:0017144) | 3.56294203 |
| 113 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.55767937 |
| 114 | regulation of plasminogen activation (GO:0010755) | 3.54556690 |
| 115 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.52162958 |
| 116 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.50542553 |
| 117 | lipoprotein metabolic process (GO:0042157) | 3.39189114 |
| 118 | ethanol metabolic process (GO:0006067) | 3.35393815 |
| 119 | heme transport (GO:0015886) | 3.29581962 |
| 120 | protein activation cascade (GO:0072376) | 3.28727972 |
| 121 | acute-phase response (GO:0006953) | 3.25170560 |
| 122 | complement activation, classical pathway (GO:0006958) | 3.23836934 |
| 123 | phenylpropanoid metabolic process (GO:0009698) | 3.19966454 |
| 124 | diacylglycerol metabolic process (GO:0046339) | 3.19795851 |
| 125 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.18318921 |
| 126 | cholesterol transport (GO:0030301) | 3.18019082 |
| 127 | sterol transport (GO:0015918) | 3.18019082 |
| 128 | regulation of apoptotic cell clearance (GO:2000425) | 3.17483611 |
| 129 | C4-dicarboxylate transport (GO:0015740) | 3.14901622 |
| 130 | L-ascorbic acid metabolic process (GO:0019852) | 3.14296974 |
| 131 | nephron epithelium morphogenesis (GO:0072088) | 3.07641732 |
| 132 | nephron tubule morphogenesis (GO:0072078) | 3.07641732 |
| 133 | negative regulation of complement activation (GO:0045916) | 3.06146590 |
| 134 | lipid homeostasis (GO:0055088) | 3.04466807 |
| 135 | fibrinolysis (GO:0042730) | 2.99717825 |
| 136 | negative regulation of blood coagulation (GO:0030195) | 2.99044578 |
| 137 | negative regulation of hemostasis (GO:1900047) | 2.99044578 |
| 138 | oxidative demethylation (GO:0070989) | 2.97307806 |
| 139 | transepithelial transport (GO:0070633) | 2.97177125 |
| 140 | positive regulation of steroid metabolic process (GO:0045940) | 2.95974144 |
| 141 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.92617302 |
| 142 | regulation of humoral immune response (GO:0002920) | 2.89323504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.02050072 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.96339189 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.28423948 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.27722431 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.36575259 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.83456066 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.49851575 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.89138957 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.62029292 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.32859909 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.21161962 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07739502 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1822334 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.88629562 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.84887233 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81665051 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.68257505 |
| 18 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.67775626 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.57337542 |
| 20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.51725209 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.49934912 |
| 22 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48405667 |
| 23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.46690958 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.38070194 |
| 25 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.35514657 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31425673 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26524909 |
| 28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25946106 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23570374 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22321079 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21041632 |
| 32 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16210871 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.15954095 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15946838 |
| 35 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13480129 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11852316 |
| 37 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10787314 |
| 38 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09344487 |
| 39 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.08694302 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07636015 |
| 41 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07059528 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.04356625 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03513765 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00930619 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.00293061 |
| 46 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99667879 |
| 47 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99106702 |
| 48 | ERA_21632823_ChIP-Seq_H3396_Human | 0.98765519 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97821746 |
| 50 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97281923 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97130984 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96780515 |
| 53 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.95337393 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.92746643 |
| 55 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.92119883 |
| 56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91949388 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91263136 |
| 58 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91230787 |
| 59 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.90686640 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90428983 |
| 61 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.89049787 |
| 62 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88319587 |
| 63 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.88314706 |
| 64 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.87607624 |
| 65 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86178792 |
| 66 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85793532 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85631008 |
| 68 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.85277430 |
| 69 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.84775741 |
| 70 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.84775741 |
| 71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.84523316 |
| 72 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.84252594 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.83895488 |
| 74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83589562 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83112819 |
| 76 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.82837493 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82823816 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82523153 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81815651 |
| 80 | STAT3_23295773_ChIP-Seq_U87_Human | 0.81571865 |
| 81 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.81400980 |
| 82 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80838642 |
| 83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79463497 |
| 84 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.78879933 |
| 85 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78543938 |
| 86 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.78123191 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77482675 |
| 88 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76882249 |
| 89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76565382 |
| 90 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76348268 |
| 91 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.75841873 |
| 92 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75231548 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 0.75153649 |
| 94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.74559415 |
| 95 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.74486175 |
| 96 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.74125976 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74037536 |
| 98 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.73600599 |
| 99 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.73170743 |
| 100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.73113600 |
| 101 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72953777 |
| 102 | NCOR_22424771_ChIP-Seq_293T_Human | 0.72858829 |
| 103 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69477699 |
| 104 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68719641 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68664360 |
| 106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68571536 |
| 107 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67448034 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67445677 |
| 109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67093947 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.65937694 |
| 111 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.64300658 |
| 112 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.62495450 |
| 113 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62373080 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61435301 |
| 115 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.59935252 |
| 116 | AR_20517297_ChIP-Seq_VCAP_Human | 0.59632265 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59413477 |
| 118 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.58661937 |
| 119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57931857 |
| 120 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.56338672 |
| 121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.55838420 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.55838420 |
| 123 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55245574 |
| 124 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.54631103 |
| 125 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53777580 |
| 126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53396144 |
| 127 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.52999085 |
| 128 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52811537 |
| 129 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52741274 |
| 130 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52062959 |
| 131 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51879243 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.51065701 |
| 133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.50464774 |
| 134 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.50123679 |
| 135 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.49783792 |
| 136 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.48650617 |
| 137 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.47776210 |
| 138 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.47765034 |
| 139 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.46935213 |
| 140 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46731770 |
| 141 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46066610 |
| 142 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.46002614 |
| 143 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45074414 |
| 144 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.44475847 |
| 145 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.44475847 |
| 146 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.43622998 |
| 147 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.43460263 |
| 148 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.42907572 |
| 149 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.42867298 |
| 150 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.42279471 |
| 151 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42155983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.97823621 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.83609197 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.84712810 |
| 4 | MP0005365_abnormal_bile_salt | 5.78461660 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.88277643 |
| 6 | MP0003252_abnormal_bile_duct | 3.94205481 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.58731816 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.33898695 |
| 9 | MP0005332_abnormal_amino_acid | 3.14900530 |
| 10 | MP0003195_calcinosis | 2.86317504 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.85759241 |
| 12 | MP0009840_abnormal_foam_cell | 2.79420821 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.70206478 |
| 14 | MP0005083_abnormal_biliary_tract | 2.54613113 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.33481577 |
| 16 | MP0003122_maternal_imprinting | 2.28030636 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.24305509 |
| 18 | MP0000609_abnormal_liver_physiology | 2.06485725 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.05167510 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.98126521 |
| 21 | MP0000566_synostosis | 1.87960483 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.84083111 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.81731757 |
| 24 | MP0003868_abnormal_feces_composition | 1.70723828 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63981489 |
| 26 | MP0001764_abnormal_homeostasis | 1.61407996 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.59294854 |
| 28 | MP0004885_abnormal_endolymph | 1.56213485 |
| 29 | MP0003123_paternal_imprinting | 1.49191356 |
| 30 | MP0005451_abnormal_body_composition | 1.48731032 |
| 31 | MP0005636_abnormal_mineral_homeostasis | 1.36784454 |
| 32 | MP0003879_abnormal_hair_cell | 1.33489142 |
| 33 | MP0004043_abnormal_pH_regulation | 1.31705057 |
| 34 | MP0005670_abnormal_white_adipose | 1.29640271 |
| 35 | MP0003186_abnormal_redox_activity | 1.29516082 |
| 36 | MP0005379_endocrine/exocrine_gland_phen | 1.27593244 |
| 37 | MP0002254_reproductive_system_inflammat | 1.26348312 |
| 38 | MP0005551_abnormal_eye_electrophysiolog | 1.25662171 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.18510869 |
| 40 | MP0002089_abnormal_postnatal_growth/wei | 1.14102218 |
| 41 | MP0001756_abnormal_urination | 1.13536660 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.12999923 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.12310453 |
| 44 | MP0000598_abnormal_liver_morphology | 1.12067445 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.11010055 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.09795767 |
| 47 | MP0009697_abnormal_copulation | 1.05999013 |
| 48 | MP0001944_abnormal_pancreas_morphology | 1.05073264 |
| 49 | MP0009764_decreased_sensitivity_to | 1.01228576 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.01145861 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.00153074 |
| 52 | MP0003283_abnormal_digestive_organ | 0.98116831 |
| 53 | MP0005647_abnormal_sex_gland | 0.97772476 |
| 54 | MP0004270_analgesia | 0.97152053 |
| 55 | MP0003011_delayed_dark_adaptation | 0.95801432 |
| 56 | MP0002136_abnormal_kidney_physiology | 0.94772230 |
| 57 | MP0000604_amyloidosis | 0.94460370 |
| 58 | MP0004742_abnormal_vestibular_system | 0.93616122 |
| 59 | MP0009642_abnormal_blood_homeostasis | 0.89819017 |
| 60 | MP0001765_abnormal_ion_homeostasis | 0.89651063 |
| 61 | MP0009763_increased_sensitivity_to | 0.89421242 |
| 62 | MP0002971_abnormal_brown_adipose | 0.88375752 |
| 63 | MP0002132_abnormal_respiratory_system | 0.87624303 |
| 64 | MP0008469_abnormal_protein_level | 0.87591593 |
| 65 | MP0003172_abnormal_lysosome_physiology | 0.86585177 |
| 66 | MP0002693_abnormal_pancreas_physiology | 0.83877089 |
| 67 | MP0001485_abnormal_pinna_reflex | 0.83849586 |
| 68 | MP0010234_abnormal_vibrissa_follicle | 0.83116105 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 0.82403757 |
| 70 | MP0005220_abnormal_exocrine_pancreas | 0.81829595 |
| 71 | MP0001661_extended_life_span | 0.80828638 |
| 72 | MP0005666_abnormal_adipose_tissue | 0.80509961 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 0.79787312 |
| 74 | * MP0006036_abnormal_mitochondrial_physio | 0.79508934 |
| 75 | MP0005535_abnormal_body_temperature | 0.79326983 |
| 76 | MP0005408_hypopigmentation | 0.78194802 |
| 77 | MP0004130_abnormal_muscle_cell | 0.77883341 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.73976922 |
| 79 | MP0005334_abnormal_fat_pad | 0.72158501 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.71895695 |
| 81 | MP0002938_white_spotting | 0.71615164 |
| 82 | MP0002928_abnormal_bile_duct | 0.71017580 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.70941013 |
| 84 | MP0002557_abnormal_social/conspecific_i | 0.70823582 |
| 85 | MP0005376_homeostasis/metabolism_phenot | 0.69659647 |
| 86 | MP0002796_impaired_skin_barrier | 0.67690088 |
| 87 | MP0002160_abnormal_reproductive_system | 0.62978047 |
| 88 | MP0003890_abnormal_embryonic-extraembry | 0.61236576 |
| 89 | MP0005410_abnormal_fertilization | 0.60915834 |
| 90 | MP0002163_abnormal_gland_morphology | 0.60656171 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.60352673 |
| 92 | MP0002064_seizures | 0.59498374 |
| 93 | MP0001501_abnormal_sleep_pattern | 0.59423180 |
| 94 | MP0003121_genomic_imprinting | 0.59362926 |
| 95 | MP0003329_amyloid_beta_deposits | 0.58499198 |
| 96 | MP0005448_abnormal_energy_balance | 0.57694816 |
| 97 | MP0004133_heterotaxia | 0.56511673 |
| 98 | MP0000678_abnormal_parathyroid_gland | 0.56215777 |
| 99 | MP0001984_abnormal_olfaction | 0.55554966 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.55376859 |
| 101 | MP0001270_distended_abdomen | 0.54971927 |
| 102 | MP0000631_abnormal_neuroendocrine_gland | 0.54722367 |
| 103 | MP0005266_abnormal_metabolism | 0.54459342 |
| 104 | MP0009046_muscle_twitch | 0.53229768 |
| 105 | MP0005058_abnormal_lysosome_morphology | 0.52640000 |
| 106 | MP0003724_increased_susceptibility_to | 0.52525247 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.52096666 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.51935166 |
| 109 | MP0005395_other_phenotype | 0.51284080 |
| 110 | MP0002229_neurodegeneration | 0.51229325 |
| 111 | MP0006292_abnormal_olfactory_placode | 0.51077091 |
| 112 | MP0005452_abnormal_adipose_tissue | 0.50862252 |
| 113 | MP0003690_abnormal_glial_cell | 0.50541705 |
| 114 | MP0009053_abnormal_anal_canal | 0.50063898 |
| 115 | MP0000538_abnormal_urinary_bladder | 0.49657463 |
| 116 | MP0002069_abnormal_eating/drinking_beha | 0.49353935 |
| 117 | MP0009115_abnormal_fat_cell | 0.49326246 |
| 118 | MP0003787_abnormal_imprinting | 0.48252930 |
| 119 | MP0003953_abnormal_hormone_level | 0.48186812 |
| 120 | MP0000230_abnormal_systemic_arterial | 0.47815723 |
| 121 | MP0001664_abnormal_digestion | 0.46167869 |
| 122 | MP0009745_abnormal_behavioral_response | 0.45632571 |
| 123 | MP0005187_abnormal_penis_morphology | 0.44773836 |
| 124 | MP0003633_abnormal_nervous_system | 0.44742944 |
| 125 | MP0002168_other_aberrant_phenotype | 0.44681848 |
| 126 | MP0005464_abnormal_platelet_physiology | 0.44429818 |
| 127 | MP0002098_abnormal_vibrissa_morphology | 0.43517488 |
| 128 | MP0008961_abnormal_basal_metabolism | 0.42966920 |
| 129 | MP0002970_abnormal_white_adipose | 0.40360140 |
| 130 | MP0008873_increased_physiological_sensi | 0.39879089 |
| 131 | MP0008872_abnormal_physiological_respon | 0.39691938 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.39588022 |
| 133 | MP0002135_abnormal_kidney_morphology | 0.39160901 |
| 134 | MP0001881_abnormal_mammary_gland | 0.38901919 |
| 135 | MP0005166_decreased_susceptibility_to | 0.38544943 |
| 136 | MP0008874_decreased_physiological_sensi | 0.38169458 |
| 137 | MP0003718_maternal_effect | 0.38065995 |
| 138 | MP0003075_altered_response_to | 0.37749556 |
| 139 | MP0001845_abnormal_inflammatory_respons | 0.36894596 |
| 140 | MP0000639_abnormal_adrenal_gland | 0.36573960 |
| 141 | MP0009672_abnormal_birth_weight | 0.36064405 |
| 142 | MP0003436_decreased_susceptibility_to | 0.35852263 |
| 143 | MP0009384_cardiac_valve_regurgitation | 0.35758483 |
| 144 | MP0000579_abnormal_nail_morphology | 0.35142431 |
| 145 | MP0005375_adipose_tissue_phenotype | 0.34349630 |
| 146 | MP0002060_abnormal_skin_morphology | 0.33962120 |
| 147 | MP0004381_abnormal_hair_follicle | 0.33234721 |
| 148 | MP0003959_abnormal_lean_body | 0.30762294 |
| 149 | MP0004185_abnormal_adipocyte_glucose | 0.30026791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.52105187 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.46408315 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.22339845 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.90965614 |
| 5 | Xanthomatosis (HP:0000991) | 5.68371023 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.50268984 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.26743320 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.99128297 |
| 9 | Hyperglycinuria (HP:0003108) | 4.88886879 |
| 10 | Hyperammonemia (HP:0001987) | 4.65292181 |
| 11 | Complement deficiency (HP:0004431) | 4.55881660 |
| 12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.54599247 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.54599247 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 4.54481798 |
| 15 | Ketosis (HP:0001946) | 4.50687702 |
| 16 | Hyperglycinemia (HP:0002154) | 4.43892312 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.21980312 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16319163 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.13714153 |
| 20 | Joint hemorrhage (HP:0005261) | 4.05095212 |
| 21 | Epidermoid cyst (HP:0200040) | 4.00727486 |
| 22 | Fat malabsorption (HP:0002630) | 3.86899910 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.82443556 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.80601122 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.79798725 |
| 26 | Gout (HP:0001997) | 3.79676566 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.77240533 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.59391837 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.57847414 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.57785899 |
| 31 | Ketoacidosis (HP:0001993) | 3.56843428 |
| 32 | Abnormality of purine metabolism (HP:0004352) | 3.53698569 |
| 33 | Abnormality of nucleobase metabolism (HP:0010932) | 3.48798018 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.38996917 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33017178 |
| 36 | Delayed CNS myelination (HP:0002188) | 3.31778395 |
| 37 | Abnormality of complement system (HP:0005339) | 3.26079067 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.18336327 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.16004893 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.05778293 |
| 41 | Metabolic acidosis (HP:0001942) | 3.01939124 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.97904683 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 2.95740827 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.95740827 |
| 45 | Abnormality of the nasal septum (HP:0000419) | 2.93166162 |
| 46 | Proximal tubulopathy (HP:0000114) | 2.87388187 |
| 47 | Vascular calcification (HP:0004934) | 2.84022610 |
| 48 | Generalized aminoaciduria (HP:0002909) | 2.82284890 |
| 49 | Alkalosis (HP:0001948) | 2.80506759 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.78799046 |
| 51 | Steatorrhea (HP:0002570) | 2.76663713 |
| 52 | Malnutrition (HP:0004395) | 2.75877210 |
| 53 | Increased purine levels (HP:0004368) | 2.74704932 |
| 54 | Hyperuricemia (HP:0002149) | 2.74704932 |
| 55 | Lethargy (HP:0001254) | 2.72257648 |
| 56 | Abnormality of proline metabolism (HP:0010907) | 2.68574619 |
| 57 | Hydroxyprolinuria (HP:0003080) | 2.68574619 |
| 58 | Metabolic alkalosis (HP:0200114) | 2.67168340 |
| 59 | Potter facies (HP:0002009) | 2.62681286 |
| 60 | Facial shape deformation (HP:0011334) | 2.62681286 |
| 61 | Pigmentary retinal degeneration (HP:0001146) | 2.59603259 |
| 62 | Myocardial infarction (HP:0001658) | 2.58874316 |
| 63 | Cardiovascular calcification (HP:0011915) | 2.51183972 |
| 64 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.49734054 |
| 65 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.45201230 |
| 66 | Spastic diplegia (HP:0001264) | 2.44983398 |
| 67 | Acanthocytosis (HP:0001927) | 2.44203779 |
| 68 | Irritability (HP:0000737) | 2.40138832 |
| 69 | Glycosuria (HP:0003076) | 2.37791729 |
| 70 | Abnormality of urine glucose concentration (HP:0011016) | 2.37791729 |
| 71 | Pancreatitis (HP:0001733) | 2.37024829 |
| 72 | Spontaneous abortion (HP:0005268) | 2.36680763 |
| 73 | Arthropathy (HP:0003040) | 2.35050424 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.34960920 |
| 75 | Skin nodule (HP:0200036) | 2.34628842 |
| 76 | Vomiting (HP:0002013) | 2.33076916 |
| 77 | Enlarged kidneys (HP:0000105) | 2.29473863 |
| 78 | Neonatal onset (HP:0003623) | 2.29198488 |
| 79 | Hypothermia (HP:0002045) | 2.28847427 |
| 80 | Abnormality of the renal cortex (HP:0011035) | 2.28369606 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.27967220 |
| 82 | Abnormal tarsal ossification (HP:0008369) | 2.26675229 |
| 83 | Late onset (HP:0003584) | 2.26045772 |
| 84 | Rectal prolapse (HP:0002035) | 2.25753148 |
| 85 | Hypochromic microcytic anemia (HP:0004840) | 2.24696614 |
| 86 | Hypophosphatemic rickets (HP:0004912) | 2.23843721 |
| 87 | Cerebral edema (HP:0002181) | 2.22132329 |
| 88 | Hypoglycemic seizures (HP:0002173) | 2.20682915 |
| 89 | Rickets (HP:0002748) | 2.18789036 |
| 90 | Broad alveolar ridges (HP:0000187) | 2.18374902 |
| 91 | Abnormality of the vitreous humor (HP:0004327) | 2.15410256 |
| 92 | Esophageal varix (HP:0002040) | 2.15048674 |
| 93 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.12045767 |
| 94 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.12045767 |
| 95 | Abnormality of chloride homeostasis (HP:0011422) | 2.11270093 |
| 96 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.09635167 |
| 97 | Abnormal urine output (HP:0012590) | 2.09218120 |
| 98 | Abnormality of renal excretion (HP:0011036) | 2.08314330 |
| 99 | Hypomagnesemia (HP:0002917) | 2.07739263 |
| 100 | Nephritis (HP:0000123) | 2.04834295 |
| 101 | Abnormal gallbladder morphology (HP:0012437) | 2.04632919 |
| 102 | Glomerulonephritis (HP:0000099) | 2.03413303 |
| 103 | Cholelithiasis (HP:0001081) | 2.02042119 |
| 104 | Widely patent fontanelles and sutures (HP:0004492) | 2.01990527 |
| 105 | Nephrolithiasis (HP:0000787) | 1.99951022 |
| 106 | Hyperactive renin-angiotensin system (HP:0000841) | 1.98089924 |
| 107 | Hypokalemic alkalosis (HP:0001949) | 1.97270451 |
| 108 | Cholecystitis (HP:0001082) | 1.97209132 |
| 109 | Abnormal gallbladder physiology (HP:0012438) | 1.97209132 |
| 110 | Thrombophlebitis (HP:0004418) | 1.96919847 |
| 111 | Abnormality of vitamin B metabolism (HP:0004340) | 1.96670999 |
| 112 | Mitral stenosis (HP:0001718) | 1.95988750 |
| 113 | Brushfield spots (HP:0001088) | 1.93833721 |
| 114 | Hyperglycemia (HP:0003074) | 1.93596737 |
| 115 | Increased circulating renin level (HP:0000848) | 1.92305178 |
| 116 | Hemorrhage of the eye (HP:0011885) | 1.92101723 |
| 117 | Renal cortical cysts (HP:0000803) | 1.92042562 |
| 118 | Hyperphosphaturia (HP:0003109) | 1.91138658 |
| 119 | Abnormal cartilage morphology (HP:0002763) | 1.90266360 |
| 120 | Amyloidosis (HP:0011034) | 1.89497117 |
| 121 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.85918236 |
| 122 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85778090 |
| 123 | Abnormality of vitamin metabolism (HP:0100508) | 1.85447588 |
| 124 | Opisthotonus (HP:0002179) | 1.85189321 |
| 125 | Megaloblastic anemia (HP:0001889) | 1.84521182 |
| 126 | Hepatoblastoma (HP:0002884) | 1.83831173 |
| 127 | Menorrhagia (HP:0000132) | 1.83262423 |
| 128 | Abnormality of magnesium homeostasis (HP:0004921) | 1.82282465 |
| 129 | Nausea (HP:0002018) | 1.82056307 |
| 130 | Confusion (HP:0001289) | 1.80364385 |
| 131 | Bifid scrotum (HP:0000048) | 1.79833071 |
| 132 | Increased serum pyruvate (HP:0003542) | 1.79481989 |
| 133 | Status epilepticus (HP:0002133) | 1.75514996 |
| 134 | Abnormality of glycolysis (HP:0004366) | 1.73794586 |
| 135 | Glomerulosclerosis (HP:0000096) | 1.73763157 |
| 136 | Bronchomalacia (HP:0002780) | 1.72649259 |
| 137 | Abnormal urine phosphate concentration (HP:0012599) | 1.71885466 |
| 138 | Abnormality of potassium homeostasis (HP:0011042) | 1.70382891 |
| 139 | Hyperaldosteronism (HP:0000859) | 1.70100734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.45851360 |
| 2 | FGFR4 | 3.87820328 |
| 3 | ERN1 | 3.83959862 |
| 4 | SIK1 | 3.74389999 |
| 5 | TAOK3 | 3.14141472 |
| 6 | MST1R | 2.82531701 |
| 7 | WNK4 | 2.71142821 |
| 8 | WNK3 | 2.60537470 |
| 9 | INSRR | 2.52337097 |
| 10 | FRK | 2.34357183 |
| 11 | ACVR1B | 2.34313619 |
| 12 | AKT3 | 2.30992349 |
| 13 | OXSR1 | 2.19706033 |
| 14 | ERBB4 | 2.11838658 |
| 15 | TRIB3 | 2.09556746 |
| 16 | PKN2 | 1.98959093 |
| 17 | NUAK1 | 1.89161035 |
| 18 | MAPKAPK3 | 1.77908681 |
| 19 | LATS1 | 1.77363612 |
| 20 | PTK6 | 1.72634697 |
| 21 | MAPK11 | 1.72340525 |
| 22 | CASK | 1.68044926 |
| 23 | GRK1 | 1.63742019 |
| 24 | FLT3 | 1.58445747 |
| 25 | MAP2K4 | 1.53932302 |
| 26 | MST4 | 1.52023601 |
| 27 | STK38L | 1.48640578 |
| 28 | FGFR1 | 1.47517565 |
| 29 | NTRK3 | 1.45650000 |
| 30 | NLK | 1.45619200 |
| 31 | PIK3CG | 1.42751595 |
| 32 | PDK4 | 1.42712242 |
| 33 | PDK3 | 1.42712242 |
| 34 | GRK6 | 1.41855287 |
| 35 | EPHB1 | 1.36328592 |
| 36 | TYK2 | 1.34882989 |
| 37 | MAP3K7 | 1.34753351 |
| 38 | FGFR2 | 1.32153000 |
| 39 | PRKAA2 | 1.30846372 |
| 40 | PHKG1 | 1.29900847 |
| 41 | PHKG2 | 1.29900847 |
| 42 | WNK1 | 1.22854831 |
| 43 | ADRBK2 | 1.19673912 |
| 44 | MAP3K9 | 1.16561943 |
| 45 | FER | 1.15605734 |
| 46 | RIPK1 | 1.14904959 |
| 47 | JAK2 | 1.13359663 |
| 48 | CAMK1D | 1.10746340 |
| 49 | NEK9 | 1.06261244 |
| 50 | MAP3K10 | 1.05025241 |
| 51 | ABL2 | 1.02075442 |
| 52 | BMPR1B | 0.99412079 |
| 53 | STK39 | 0.93322103 |
| 54 | MAP2K3 | 0.93179345 |
| 55 | CSNK1G1 | 0.91905375 |
| 56 | MAP3K3 | 0.91179932 |
| 57 | SGK3 | 0.91115340 |
| 58 | JAK1 | 0.88813644 |
| 59 | MET | 0.88218584 |
| 60 | PAK3 | 0.87680611 |
| 61 | DAPK2 | 0.86704176 |
| 62 | KDR | 0.82121667 |
| 63 | SGK1 | 0.81395520 |
| 64 | PRKCI | 0.81081820 |
| 65 | PRKAA1 | 0.81041324 |
| 66 | ERBB2 | 0.80939114 |
| 67 | MAPK4 | 0.80854813 |
| 68 | ICK | 0.79997175 |
| 69 | ZAK | 0.78344983 |
| 70 | PINK1 | 0.78341386 |
| 71 | IRAK3 | 0.77627613 |
| 72 | GSK3A | 0.77049631 |
| 73 | FGFR3 | 0.75965782 |
| 74 | PDK2 | 0.74811975 |
| 75 | CSNK1E | 0.74810757 |
| 76 | MAP4K2 | 0.73750276 |
| 77 | TBK1 | 0.73529421 |
| 78 | EPHA4 | 0.73395708 |
| 79 | PRKCZ | 0.71691876 |
| 80 | SGK494 | 0.71414851 |
| 81 | SGK223 | 0.71414851 |
| 82 | CDK6 | 0.71395895 |
| 83 | MAP3K14 | 0.71146759 |
| 84 | MAPK15 | 0.70858583 |
| 85 | PDPK1 | 0.68115526 |
| 86 | PTK2 | 0.67632716 |
| 87 | SIK2 | 0.67584965 |
| 88 | CDK3 | 0.66738123 |
| 89 | PRKCG | 0.65285748 |
| 90 | TNIK | 0.64625435 |
| 91 | SGK2 | 0.63926453 |
| 92 | CAMK1G | 0.63398191 |
| 93 | CSK | 0.62346720 |
| 94 | PRKACG | 0.61846775 |
| 95 | EPHA3 | 0.60313975 |
| 96 | MAP2K6 | 0.60283740 |
| 97 | CSNK1A1 | 0.60219528 |
| 98 | NME1 | 0.58054901 |
| 99 | DYRK1B | 0.56998813 |
| 100 | LRRK2 | 0.56858427 |
| 101 | CHUK | 0.56782539 |
| 102 | CDK12 | 0.55943772 |
| 103 | RPS6KB1 | 0.55284283 |
| 104 | PNCK | 0.52256478 |
| 105 | MAP2K2 | 0.49558959 |
| 106 | PDK1 | 0.49414816 |
| 107 | EIF2AK1 | 0.49357237 |
| 108 | TYRO3 | 0.49328863 |
| 109 | MAP3K6 | 0.47837804 |
| 110 | TIE1 | 0.47184431 |
| 111 | STK10 | 0.46023629 |
| 112 | TGFBR2 | 0.45286630 |
| 113 | MAPK12 | 0.44980362 |
| 114 | RPS6KB2 | 0.43535783 |
| 115 | AKT2 | 0.43486635 |
| 116 | STK3 | 0.43007789 |
| 117 | MAP3K2 | 0.42662750 |
| 118 | CAMK2D | 0.41912145 |
| 119 | TNK2 | 0.41274428 |
| 120 | PRKCQ | 0.41228142 |
| 121 | MAPKAPK5 | 0.40202750 |
| 122 | MTOR | 0.38855046 |
| 123 | MAP2K1 | 0.38219150 |
| 124 | MAP3K11 | 0.38073949 |
| 125 | CDK4 | 0.37883961 |
| 126 | STK38 | 0.37883677 |
| 127 | RET | 0.37199072 |
| 128 | CDC42BPA | 0.35628827 |
| 129 | IRAK1 | 0.35380501 |
| 130 | PRKD3 | 0.34919985 |
| 131 | PRKACA | 0.33884542 |
| 132 | CAMK2G | 0.33695046 |
| 133 | IGF1R | 0.33452545 |
| 134 | LMTK2 | 0.33374371 |
| 135 | CSNK1D | 0.32874589 |
| 136 | MYLK | 0.32669166 |
| 137 | PRKCE | 0.32505392 |
| 138 | RPS6KA3 | 0.32374851 |
| 139 | NEK1 | 0.31901888 |
| 140 | ZAP70 | 0.30684335 |
| 141 | ITK | 0.30486886 |
| 142 | PRKG1 | 0.30124281 |
| 143 | PRKG2 | 0.29341748 |
| 144 | MAPK14 | 0.28785627 |
| 145 | EPHA2 | 0.28721484 |
| 146 | EEF2K | 0.27273819 |
| 147 | IKBKE | 0.26879634 |
| 148 | MAP3K5 | 0.26562049 |
| 149 | MAP4K1 | 0.25559083 |
| 150 | PIK3CA | 0.25515273 |
| 151 | ABL1 | 0.25257373 |
| 152 | MAP3K13 | 0.25178411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.96917543 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41822583 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.31712857 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.99081953 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.83015684 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.76135570 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73238670 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.69503845 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.66489122 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52550593 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.38071748 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.37045487 |
| 13 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31500553 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.31411662 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.25343002 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.19565059 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.99075400 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.98838448 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.96833376 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94270659 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87213015 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.86267901 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.74963869 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74007823 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73148133 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70421245 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68631083 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68075071 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.66193044 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.61328871 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59610519 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58103638 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51547156 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.51499425 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49447195 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41695982 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41591557 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41347726 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40622024 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38597645 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34697845 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30556996 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27009998 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27005622 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.26372922 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22451862 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19339999 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18957408 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.17883679 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12984094 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12511924 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02504035 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99961436 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99925578 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.99388191 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.95580459 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90954309 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86449733 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83064650 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81275506 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80599352 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80172080 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79758172 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68204315 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65690023 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62625231 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57332106 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53590054 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49449383 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.49108398 |
| 71 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47400434 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38483347 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38017285 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31483710 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.29724927 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28828516 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.28273806 |
| 78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28048215 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27537054 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23617668 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22916530 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.18754431 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17909277 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17040222 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.13015611 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11765813 |
| 87 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.09794225 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.09262719 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08884163 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08780638 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08654983 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.06553573 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.05828549 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.04498468 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.01986180 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.01959120 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.01573006 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00133579 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2048644 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.2007817 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1991307 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1909440 |
| 103 | Lysosome_Homo sapiens_hsa04142 | -0.1740060 |
| 104 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1483787 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1459845 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1387327 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | -0.1331527 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1096779 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0889020 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0708938 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0699800 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0630830 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0622257 |

